Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Goodwill and Intangible Assets 2010-2025 | MKKGY

Merck goodwill and intangible assets from 2010 to 2025. Goodwill and intangible assets can be defined as the sum of all intangible asset fields
  • Merck goodwill and intangible assets for the quarter ending March 31, 2025 were $25.870B, a 3.38% decline year-over-year.
  • Merck goodwill and intangible assets for 2024 were $27.522B, a 4.24% increase from 2023.
  • Merck goodwill and intangible assets for 2023 were $26.404B, a 2.55% decline from 2022.
  • Merck goodwill and intangible assets for 2022 were $27.095B, a 6.96% decline from 2021.
  
Merck Annual Goodwill and Intangible Assets
(Millions of US $)
2024 $27,522
2023 $26,404
2022 $27,095
2021 $29,123
2020 $26,972
2019 $29,474
2018 $24,802
2017 $24,752
2016 $27,653
2015 $28,119
2014 $15,148
2013 $13,107
2012 $14,076
2011 $16,388
2010 $0
2009 $0
Merck Quarterly Goodwill and Intangible Assets
(Millions of US $)
2025-03-31 $25,870
2024-12-31 $27,522
2024-09-30 $26,322
2024-06-30 $26,415
2024-03-31 $26,776
2023-12-31 $26,404
2023-09-30 $27,408
2023-06-30 $27,115
2023-03-31 $26,868
2022-12-31 $27,095
2022-09-30 $27,813
2022-06-30 $28,132
2022-03-31 $28,403
2021-12-31 $29,123
2021-09-30 $28,652
2021-06-30 $28,869
2021-03-31 $29,303
2020-12-31 $26,972
2020-09-30 $28,856
2020-06-30 $28,389
2020-03-31 $29,196
2019-12-31 $29,474
2019-09-30 $23,395
2019-06-30 $23,166
2019-03-31 $23,872
2018-12-31 $24,802
2018-09-30 $24,629
2018-06-30 $25,637
2018-03-31 $26,012
2017-12-31 $24,752
2017-09-30 $26,307
2017-06-30 $25,453
2017-03-31 $26,284
2016-12-31 $27,653
2016-09-30 $26,759
2016-06-30 $27,583
2016-03-31 $26,951
2015-12-31 $28,119
2015-09-30 $12,691
2015-06-30 $12,988
2015-03-31 $13,243
2014-12-31 $15,148
2014-09-30 $15,300
2014-06-30 $15,673
2014-03-31 $13,278
2013-12-31 $13,107
2013-09-30 $13,620
2013-06-30 $13,804
2013-03-31 $14,299
2012-12-31 $14,076
2012-09-30 $13,984
2012-06-30 $14,688
2012-03-31
2011-12-31 $16,388
2011-09-30
2011-06-30 $16,840
2011-03-31
2010-12-31
2010-09-30 $16,584
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $17.150B $22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.582B 28.73
Zoetis (ZTS) United States $68.989B 25.74
Takeda Pharmaceutical (TAK) Japan $46.711B 9.29
Daiichi Sankyo, - (DSNKY) Japan $41.733B 21.39
BeOne Medicines - (ONC) Cayman Islands $27.433B 0.00
Sandoz Group AG (SDZNY) Switzerland $24.614B 0.00
Summit Therapeutics (SMMT) United States $18.567B 0.00
Shionogi (SGIOY) Japan $14.207B 0.00
United Therapeutics (UTHR) United States $13.330B 11.79
Neurocrine Biosciences (NBIX) United States $13.208B 45.24
Orion OYJ (ORINY) Finland $11.038B 29.85
IPSEN (IPSEY) France $10.299B 0.00
Stevanato Group S.p.A (STVN) Italy $7.635B 46.69
Corcept Therapeutics (CORT) United States $7.622B 61.97
Madrigal Pharmaceuticals (MDGL) United States $7.004B 0.00
Grifols, S.A (GRFS) Spain $6.697B 0.00
Ionis Pharmaceuticals (IONS) United States $6.642B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.068B 15.41
Soleno Therapeutics (SLNO) United States $4.110B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.990B 0.00
Hypermarcas (HYPMY) Brazil $2.988B 19.65
Catalyst Pharmaceuticals (CPRX) United States $2.660B 9.32
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.611B 14.12
NewAmsterdam Pharma (NAMS) Netherlands $2.418B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.927B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.833B 0.00
Ocular Therapeutix (OCUL) United States $1.757B 0.00
ARS Pharmaceuticals (SPRY) United States $1.737B 0.00
Endo (NDOI) United States $1.602B 0.00
Evotec AG (EVO) Germany $1.445B 0.00
ProKidney (PROK) United States $1.329B 0.00
Guardian Pharmacy Services (GRDN) United States $1.291B 0.00
Harrow (HROW) United States $1.281B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.189B 23.78
Enliven Therapeutics (ELVN) United States $1.102B 0.00
Ardelyx (ARDX) United States $1.074B 0.00
Collegium Pharmaceutical (COLL) United States $1.045B 5.64
Akebia Therapeutics (AKBA) United States $1.032B 0.00
Verve Therapeutics (VERV) United States $0.983B 0.00
Dyne Therapeutics (DYN) United States $0.982B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.930B 0.00
Cronos Group (CRON) Canada $0.806B 0.00
Xeris Biopharma Holdings (XERS) United States $0.799B 0.00
KalVista Pharmaceuticals (KALV) United States $0.725B 0.00
Zevra Therapeutics (ZVRA) United States $0.685B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.685B 0.00
Xencor (XNCR) United States $0.628B 0.00
Relay Therapeutics (RLAY) United States $0.617B 0.00
USANA Health Sciences (USNA) United States $0.614B 13.36
Bioventus (BVS) United States $0.573B 14.52
Theravance Biopharma (TBPH) United States $0.565B 0.00
Elite Pharmaceuticals (ELTP) United States $0.554B 0.00
Organogenesis (ORGO) United States $0.545B 0.00
Oruka Therapeutics (ORKA) United States $0.533B 0.00
Siga Technologies (SIGA) United States $0.484B 10.10
Tourmaline Bio (TRML) United States $0.462B 0.00
Savara (SVRA) United States $0.413B 0.00
Aquestive Therapeutics (AQST) United States $0.398B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.337B 9.12
Altimmune (ALT) United States $0.336B 0.00
Heron Therapeutics (HRTX) United States $0.333B 0.00
Nektar Therapeutics (NKTR) United States $0.310B 0.00
AleAnna (ANNA) United States $0.310B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.301B 0.00
Nature's Sunshine Products (NATR) United States $0.288B 26.48
Aldeyra Therapeutics (ALDX) United States $0.279B 0.00
OmniAb (OABI) United States $0.248B 0.00
Nanobiotix S.A (NBTX) France $0.244B 0.00
Esperion Therapeutics (ESPR) United States $0.236B 0.00
MediWound (MDWD) Israel $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.216B 0.00
China SXT Pharmaceuticals (SXTC) China $0.203B 0.00
4D Molecular Therapeutics (FDMT) United States $0.198B 0.00
Profound Medical (PROF) Canada $0.175B 0.00
Liminatus Pharma (LIMN) United States $0.173B 0.00
Aclaris Therapeutics (ACRS) United States $0.170B 0.00
Journey Medical (DERM) United States $0.167B 0.00
Galectin Therapeutics (GALT) United States $0.159B 0.00
Avita Medical (RCEL) United States $0.151B 0.00
Lexeo Therapeutics (LXEO) United States $0.148B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Inhibikase Therapeutics (IKT) United States $0.138B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.122B 0.00
Korro Bio (KRRO) United States $0.119B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.112B 18.41
Innate Pharma SA (IPHYF) France $0.110B 0.00
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Cassava Sciences (SAVA) United States $0.103B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Nutriband (NTRB) United States $0.089B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Vivani Medical (VANI) United States $0.083B 0.00
Metagenomi (MGX) United States $0.081B 0.00
Achieve Life Sciences (ACHV) Canada $0.080B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Jupiter Neurosciences (JUNS) United States $0.076B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.075B 0.00
Surrozen (SRZN) United States $0.075B 0.00
Fractyl Health (GUTS) United States $0.074B 0.00
Dominari Holdings (DOMH) United States $0.073B 0.00
Rafael Holdings (RFL) United States $0.073B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Klotho Neurosciences (KLTO) United States $0.069B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
PMV Pharmaceuticals (PMVP) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.045B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 33.33
Mural Oncology (MURA) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.041B 0.00
Vivos Therapeutics (VVOS) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
Telomir Pharmaceuticals (TELO) United States $0.035B 0.00
PolyPid (PYPD) Israel $0.034B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
FibroGen (FGEN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Natural Alternatives (NAII) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.020B 0.00
DURECT (DRRX) United States $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.019B 0.00
Plus Therapeutics (PSTV) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
BioVie (BIVI) United States $0.013B 0.00
Ainos (AIMD) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.05
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.05
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00